Browse Category


Mario Tama/Getty Images

Why do more men die of COVID? It’s likely not what you think

9 mins read

GenderSci Lab finds social factors, not biological difference between sexes, play biggest role by far. Researchers agree that men die of COVID at a higher rate than women, but they haven’t been sure why. A new Harvard GenderSci Lab study of more than 30 million confirmed coronavirus cases in the U.S. suggests the reason has less…

FILE PHOTO: People, some wearing protective face masks, walk over Westminster Bridge, amid the coronavirus disease (COVID-19) pandemic, in London, Britain, July 4, 2021. REUTERS/Henry Nicholls/File Photo

Omicron Optimism and Shift from Pandemic to Endemic

8 mins read

With Omicron’s surge peaking in some U.S. states, experts this week sounded a wary note of optimism that better times are weeks to months away, but they warn that prospects of an “end” are murky, with the likeliest scenario being one in which the virus shifts from pandemic to a more manageable endemic mode.…

How Lockdown Affected People’s Sex Lives

2 mins read

Over 6,500 people took part in the web-panel study, which saw Glasgow academics partner with researchers from University College London and the National Centre for Social Research (NatCen).…

Four ways nature can protect your well-being during a pandemic

12 mins read

Living through the COVID-19 pandemic has had a severe impact on people’s mental health and well-being. Restricted movement, loss, and isolation have led to increases in depression, anxiety disorders, stress, sleep disorders, and more. The effects have been even harsher for teens.…

No Omicron immunity without booster, study finds

5 mins read

The FINANCIAL — An additional “booster” dose of Moderna or Pfizer mRNA-based vaccine is needed to provide immunity against the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, according to a study by researchers at the Ragon Institute of MGH, MIT and Harvard.…

Covid-19 Vaccine Protection Wanes After Three Months, Study Suggests

5 mins read

The FINANCIAL — The protection offered by the Oxford-Astra Zeneca Covid-19 vaccine declines after three months of receiving two doses, a study says, University of Glasgow says.…

Millions embrace COVID-19 misinformation, which is linked to vaccine hesitancy

2 mins read

The FINANCIAL — In the fourth survey conducted with a nationally representative sample of more than 1,600 U.S. adults, in November 2021 the Annenberg Public Policy Center continued its tracking of misbeliefs and conspiracy theories that have persisted and, in rare cases, grown since the inception of the pandemic.…

COVID-19 vaccine volunteers share their stories, one year later

6 mins read

The FINANCIAL —  Within the space of one momentous week in December 2020, vaccines to prevent COVID-19 from both Pfizer–BioNTech and Moderna became the first mrRNA vaccines authorized for widespread use, according to University of Pennsylvania.…

Needle-free vaccine targets COVID-19 variants and future coronaviruses

7 mins read

Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive the vaccine today at the NIHR Southampton Clinical Research Facility.…

Time of day matters when getting vaccine

6 mins read

Antibody levels higher when people receive SARS-CoV-2 vaccine in the afternoon, say researchers. Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination. A new study published in the Journal of Biological Rhythms demonstrates that antibody levels are higher when people receive the SARS-CoV-2 vaccine in the afternoon…

New COVID-19 study for immunocompromised people

7 mins read

The FINANCIAL — A new national study is recruiting immunocompromised people to determine their immune response to COVID-19 vaccination over six months.…

90% of countries have published vaccine plans: Oxford Covid policy tracker

3 mins read

The FINANCIAL — More than nine in ten countries, studied as part of the Oxford COVID-19 Government Response Tracker (167 out of 187), have published an official vaccination plan, with the top three priority categories internationally being older people, frontline healthcare workers, and the clinically vulnerable. Other categories widely prioritised are educators, military, border security…

Spike protein encounters determine protection against variants

8 mins read

The FINANCIAL — New research shows that the first SARS-CoV-2 spike protein a person encounters shapes their subsequent immune response against current and future variants.…

COVID-19 Delta Variant May Have Increased Ability to Evade Vaccine-Induced Immunity

3 mins read

The FINANCIAL — Vaccines are effective in decreasing hospitalization and deaths from COVID-19 infection but the emergence of viral variants of concern may diminish their efficacy, according to a new study, according to University of Glasgow.…

Understanding omicron, the new COVID-19 variant

7 mins read

Countries around the world are making preparations against omicron, a new variant of the novel coronavirus that causes COVID-19. On Wednesday, Dec. 1, omicron’s presence in California was confirmed by the U.S. Centers for Disease Control and Prevention.…

1 2 3 23